Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Harshali K. Patel, PhD

Advertisement

Articles by Harshali K. Patel, PhD

Who is Driving the HTA Bus? And Where is it Headed?

ByZachary Wessler,Samar Malik,Justin J. Piacentino,Jeffrey J. Lemay,Harshali K. Patel, PhD
October 9th 2019

Pharmaceutical Executive

An Exploration of the Future of Pharmaceutical Value Assessments in the U.S.

Advertisement

Latest Updated Articles

  • Who is Driving the HTA Bus? And Where is it Headed?
    Who is Driving the HTA Bus? And Where is it Headed?

    October 9th 2019



Advertisement
Advertisement

Trending on PharmExec

1

Sanofi Eyes Insmed in Potential $43B Deal as Dupixent Patent Clock Ticks

2

Pfizer, Verismo Strike Licensing Deals to Push CAR T Manufacturing In Vivo

3

FDA Approves Livsayis, Regeneron's First siRNA Therapy for Myasthenia Gravis

4

Innogen Licenses GLP-1 Therapy Efsubaglutide Alfa to Arcera

5

DISCO, AbbVie Sign AND-Gated Bispecific Deal Worth Up to $2.5B

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us